Information about us
The Site is operated by Celyad SA (“Company”, “we”, “us”, “our”). The Company is a company organized and existing under the laws of Belgium, having its registered office at Rue Edouard Belin 2, 1435 Mont-Saint-Guibert, Belgium, registered with the register of legal entities (RPM Nivelles) under number 0891.118.115. To contact us, please email us at firstname.lastname@example.org.
Changes to these terms
Changes to the Site
We may update the Site from time to time, and may change the content at any time. However, please note that any of the content on the Site may be out of date at any given time, and we are under no obligation to update it. We do not guarantee that the Site, or any content on it, will be free from errors or omissions.
Accessing the Site
Our use of your data
We may collect certain personal data, the use of which is subject to Belgian law (Law of 8 December 1992 on the protection of privacy). We will maintain security procedures with respect to its access and maintenance information you submit in queries to the Site which provide reasonably appropriate technical and organizational safeguards against unauthorized disclosure or access consistent with these terms.
By using the Site, you authorize and hereby grant Celyad SA a non-exclusive, royalty-free, world-wide, irrevocable license to reproduce, transmit, display, disclose, and otherwise use your data solely for the purposes of processing your requests and transactions, maintaining and improving the Site, but not for using your data for other commercial purposes unless otherwise provided in a separate written agreement you may have with us.
With the exception of your data referred to above, you acknowledge that we will treat any communications or material of any kind that you e-mail, post, or transmit to or through the Site, including questions, comments, suggestions and other information, as non-confidential and non-proprietary. By using the Site, you authorize and hereby grant Celyad SA a non-exclusive, royalty-free, world-wide, irrevocable license to reproduce, transmit, display, disclose, and otherwise use your communications for reasonable business purposes.
You have the right to request a copy of your personal information and have it corrected or removed from our files. Inquiries about the accuracy of identifying information previously submitted to Celyad SA through the Site, or requests to have information removed, should be directed to email@example.com.
Use of robots
We do not permit the use of robots, spiders, crawlers or the like in connection with the Site without our prior written permission. This restriction does not apply to the use of these mechanisms to index content for the Site for use in connection with search engines and other online directories.
Intellectual property rights
Celyad is a registered trademark owned by Celyad SA. Celyad SA’s or its affiliates’ trademarks may not be used in connection with any product or service that is not Celyad SA’s or its affiliates’, in any manner that is likely to cause confusion among customers, or in any manner that disparages or discredits Celyad SA and/or its affiliates. All other trademarks, service marks and logos used in the Site are the trademarks, service marks or logos of their respective owners. Celyad SA does not make any claims to the marks of others which might appear on the Site. You gain no right to use any marks of Celyad SA or any other entity by virtue of your use of the Site.
We respect the intellectual property of others, and we ask our users to do the same. If you believe that your work has been copied in a way that constitutes copyright infringement, please email us at firstname.lastname@example.org.
No reliance on information
The content on the Site is provided for general information only. It is not intended to amount to advice on which you should rely. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on the Site.
Although we make reasonable efforts to update the information on the Site, we make no representations, warranties or guarantees, whether express or implied, that the content on the Site is accurate, complete or up-to-date.
The Site is controlled and operated by Celyad SA from its offices within Belgium. Celyad SA makes no representation that materials in the Site are appropriate or available for use in other locations. Those who choose to access the Site from other locations do so on their own initiative and are responsible for compliance with local or national laws, if and to the extent local or national laws are applicable.
Limitation of liability
We will not be liable to any user for any loss or damage, whether in contract, tort (including negligence), breach of statutory duty, or otherwise, even if foreseeable, arising under or in connection with:
- use of, or inability to use, the Site; or
- use of or reliance on any content displayed on the Site.
In particular, we will not be liable for:
- loss of profits, sales, business, or revenue;
- business interruption;
- loss of anticipated savings;
- loss of business opportunity, goodwill or reputation; or
- any indirect or consequential loss or damage.
We will not be liable for any loss or damage caused by a virus, distributed denial-of-service attack, or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of the Site or to your downloading of any content on it, or on any website linked to it. We assume no responsibility for the content of websites linked to on the Site. Such links should not be interpreted as endorsement by us of those linked websites. We will not be liable for any loss or damage that may arise from your use of them.
We do not guarantee that the Site will be secure or free from bugs or viruses. You are responsible for configuring your information technology, computer programs and platform in order to access the Site. You should use your own virus protection software. You must not misuse the Site by knowingly introducing viruses, trojans, worms, logic bombs or other material which is malicious or technologically harmful. You must not attempt to gain unauthorized access to the Site, the server on which the Site is stored or any server, computer or database connected to the Site. You must not attack the Site via a denial-of-service attack or a distributed denial-of service attack. By breaching this provision, you would commit a criminal offence. We will report any such breach to the relevant law enforcement authorities and we will co-operate with those authorities by disclosing your identity to them. In the event of such a breach, your right to use the Site will cease immediately.
Linking to the Site
You may link to the home page of the Site, provided you do so in a way that is fair and legal and does not damage our reputation or take advantage of it. You must not establish a link in such a way as to suggest any form of association, approval or endorsement on our part where none exists. You must not establish a link to the Site in any website that is not owned by you. The Site must not be framed on any other site, nor may you create a link to any part of the Site other than the home page. We reserve the right to withdraw linking permission without notice. If you wish to make any use of content on the Site other than that set out above, please email us at email@example.com.
Third party links and resources in the Site
Where the Site contains links to other sites and resources provided by third parties, these links are provided for your information only. We have no control over the contents of those sites or resources.
In addition to historical facts or statements of current condition, this Site may contain forward-looking statements, including statements about the potential safety and feasibility of CYAD-01 cell therapy, including current and planned preclinical and clinical trials for Celyad’s product candidates; the clinical and commercial potential of these product candidates and the adequacy of Celyad’s financial resources; Celyad’s intellectual property portfolio, including plans related thereto; Celyad’s expectations regarding its strategic collaborations and license agreements with third parties, including, without limitation, Novartis, Celdara Medical, Ono Pharmaceuticals and Dartmouth College, and the potential impact of such collaborations on Celyad’s future financial condition; and Celyad’s expected cash burn, which reflect Celyad’s current expectations and projections about future events, and involve certain known and unknown risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These forward-looking statements are further qualified by important factors and risks, which could cause actual results to differ materially from those in the forward-looking statements, including risks associated with conducting clinical trials; the risk that safety, bioactivity, feasibility and/or efficacy demonstrated in earlier clinical trials or preclinical studies may not be replicated in subsequent trials or studies; risks associated with the timely submission and approval of anticipated regulatory filings; the successful initiation and completion of clinical trials, including its clinical trials for CYAD-01; risks associated with the satisfaction of regulatory and other requirements; risks associated with the actions of regulatory bodies and other governmental authorities; risks associated with obtaining, maintaining and protecting intellectual property, Celyad’s ability to enforce its patents against infringers and defend its patent portfolio against challenges from third parties; risks associated with competition from others developing products for similar uses; risks associated with Celyad’s ability to manage operating expenses; and risks associated with Celyad’s ability to obtain additional funding to support its business activities and establish and maintain strategic business alliances and business initiatives. A further list and description of these risks, uncertainties and other risks can be found in Celyad’s U.S. Securities and Exchange Commission (SEC) filings and reports. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date of publication. Celyad expressly disclaims any obligation to update any such forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based, unless required by law or regulation.
To contact us, please email us at firstname.lastname@example.org.
Thank you for visiting the Site.
LAST UPDATED: 21 November 2017